<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> is considered a promising antitumor agent, promoting <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and contrasting it in <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="1" pm="."><plain>The basis for this selectivity is presumed to be the ability of <z:chebi fb="9" ids="16796">melatonin</z:chebi> to stimulate reactive oxygen species (ROS) production in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Here we investigate the effect of <z:chebi fb="9" ids="16796">melatonin</z:chebi> on three types of human lymphocytes: <z:mpath ids='MPATH_458'>normal</z:mpath> blood lymphocytes, BL41 Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and the cognate Epstein-Barr virus (EBV)-converted E2r </plain></SENT>
<SENT sid="3" pm="."><plain>We found that <z:chebi fb="9" ids="16796">melatonin</z:chebi> promotes ROS production in <z:hpo ids='HP_0000001'>all</z:hpo> these cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> protects BL41 from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the same manner as <z:mpath ids='MPATH_458'>normal</z:mpath> lymphocytes, whereas E2r are unaffected </plain></SENT>
<SENT sid="5" pm="."><plain>These results show that ROS production is not limited to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> lymphocytes nor it is involved in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> promotion; that <z:chebi fb="9" ids="16796">melatonin</z:chebi> does not promote <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> lymphocytes, but EBV inhibits <z:chebi fb="9" ids="16796">melatonin</z:chebi> anti-apoptotic effects; and that the anti-apoptotic effect of <z:chebi fb="9" ids="16796">melatonin</z:chebi> does not depend on the well-known chemical <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties of <z:chebi fb="9" ids="16796">melatonin</z:chebi> </plain></SENT>
</text></document>